Related Experiment Video
Updated: Jul 8, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
Exercise-induced asthma
Kai-Håkon Carlsen1, Karin C L Carlsen
1Voksentoppen National Hospital and Research Institute of Asthma, Allergy and Chronic Lung Diseases in Children, Voksentoppen, Ullveien 14, Oslo, Norway.
Abstract:
Exercise-induced asthma (EIA) is common in asthmatic children and adolescents. Since it may cause limitations to daily life activities in up to 30%, mastering EIA is important in asthma management. EIA consists of bronchial obstruction occurring immediately, or soon after, physical exercise as a result of increased respiratory water and heat loss due to increased ventilation during exercise, with the subsequent release of mediators and stimulation of airways receptors. Diagnosis is best made by standardised exercise tests, preferably running on a treadmill for 6-8 minutes at an exercise load of 95% of maximum. The sensitivity of the test may be increased by cold air inhalation. EIA is best treated by inhaled steroids in addition to pre-treatment before exercise by inhaled beta(2)-agonists, short or long acting, and/or leukotriene antagonists. Physical training may improve physical fitness and quality of life in asthmatic children but baseline lung function and bronchial responsiveness are not improved.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma I: Introduction
Asthma III: Clinical Manifestations

